VCAM-1 complements CA-125 in detecting recurrent ovarian cancer

ConclusionsA two-marker panel of CA-125 and VCAM-1 showed strong diagnostic performance and improvement over the use of CA-125 alone in detecting recurrent ovarian cancer. The experimental results warrant further clinical validation to determine their role in the early detection of recurrent ovarian cancer.
Source: Clinical Proteomics - Category: Biochemistry Source Type: research